Related Experiment Video
Updated: Oct 23, 2025

Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms
Published on: August 11, 2015
Intracranial Aneurysms in Patients with Marfan Syndrome: A Multicenter Propensity-Matched Analysis
Ricardo A Domingo1, Carlos Perez-Vega1, Shashwat Tripathi2
1Department of Neurologic Surgery, Mayo Clinic, Jacksonville, Florida, USA.
Objective:
We sought to identify risk factors for intracranial aneurysms (IAs) in Marfan syndrome (MFS) patients and to describe their characteristics.
Methods:
Patients with confirmed MFS and vessel-dedicated brain imaging from January 1, 1980-December 1, 2020 were categorized according to the presence (IA) or absence (NIA) of IAs. Unmatched logistic regression analysis and propensity score matching were used for comparison.
Results:
We included 159 patients, of whom 18 (11.3%) patients had radiographic diagnosis of IAs. Three patients (16.7%) had multiple lesions for a total of 24 IAs. One patient (5.5%) had de novo IA formation. Four patients (22.2%) underwent treatment: Two (11.1%) had open surgical clipping for ruptured aneurysms, and two (11.1%) patients had endovascular embolization for growth. In the unmatched analysis, current tobacco smoker status (odds ratio [OR]: 4.20; confidence interval [CI]: 1.11-15.6; P = 0.027) and history of coronary artery disease (CAD) (OR: 5.79; CI 1.76-20.2; P = 0.004) increased the odds for IA. Propensity score matching yielded 18 IA and 18 NIA patients matched for age, gender, race, prior stroke, and family history of aneurysms. History of CAD (IA = 11 [61.1%] vs. NIA = 4 (22.2%), P = 0.043) and current smoker status (IA = 6 [33.3%] vs. NIA = 0 (0%), P < 0.01) were significantly higher in the IA cohort. Body mass index (P = 0.622), diabetes (P = 0.180), hypertension (P = 0.732), prior stroke (P = 1.00), family history (P = 0.732), alcohol (P = 0.314), recreational drugs (P = 1.00), and other aneurysms (P = 0.585) were not statistically significant.
Conclusions:
Prevalence of IAs in our series of MFS patients was 11.3%, and de novo formation was 5.5%. MFS patients with a history of CAD and current smoker status had an increased risk of IA. Neurovascular radiographic screening should be considered in all patients with MFS, particularly in patients who smoke or have a history of heart disease.
Insights
Marfan syndrome patients with a history of coronary artery disease and current smoking status face an increased risk of intracranial aneurysms (IAs). Neurovascular screening is recommended for all Marfan syndrome patients, especially those with these risk factors.
Area of Science:
- Cardiovascular Research
- Neurology
- Genetics
Background:
- Marfan syndrome (MFS) is a genetic disorder affecting connective tissue, increasing the risk of aortic and cardiovascular complications.
- Intracranial aneurysms (IAs) are a less commonly recognized complication in MFS patients.
- Identifying risk factors for IA in MFS is crucial for early detection and management.
Purpose of the Study:
- To determine the prevalence and risk factors associated with intracranial aneurysms (IAs) in patients diagnosed with Marfan syndrome (MFS).
- To characterize the clinical presentation and management of IAs in this patient population.
Main Methods:
- Retrospective analysis of 159 Marfan syndrome patients with brain imaging between 1980 and 2020.
- Comparison of patients with and without intracranial aneurysms using logistic regression and propensity score matching.
- Evaluation of various clinical factors, including smoking status, coronary artery disease, hypertension, and diabetes.
Main Results:
- The prevalence of intracranial aneurysms (IAs) in the studied Marfan syndrome (MFS) cohort was 11.3%.
- Current tobacco smoking (OR: 4.20) and a history of coronary artery disease (CAD) (OR: 5.79) were significantly associated with increased odds of IA.
- After propensity score matching, history of CAD (61.1% vs. 22.2%) and current smoker status (33.3% vs. 0%) remained significantly higher in the IA group.
Conclusions:
- Intracranial aneurysms (IAs) occur in 11.3% of Marfan syndrome (MFS) patients, with a 5.5% rate of de novo formation.
- A history of coronary artery disease (CAD) and current smoking are significant risk factors for IA development in MFS.
- Routine neurovascular screening is advised for all MFS patients, with particular emphasis on those who smoke or have a history of heart disease.
Related Concept Videos
Aneurysm I: Introduction
Aneurysm III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies

